Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Design Therapeutics Inc
(NQ:
DSGN
)
3.780
+0.020 (+0.53%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
108,094
Open
3.770
Bid (Size)
2.210 (5)
Ask (Size)
4.000 (2)
Prev. Close
3.760
Today's Range
3.695 - 3.800
52wk Range
1.940 - 8.470
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
March 26, 2024
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023
March 19, 2024
DSGN stock results show that Design Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Performance
YTD
+48.82%
+48.82%
1 Month
-3.32%
-3.32%
3 Month
+60.85%
+60.85%
6 Month
+87.13%
+87.13%
1 Year
-41.58%
-41.58%
More News
Read More
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results
March 19, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 19, 2024
March 19, 2024
Via
Benzinga
Earnings Preview For Design Therapeutics
March 18, 2024
Via
Benzinga
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update
March 12, 2024
From
Design Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 09, 2024
Via
Benzinga
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024
November 13, 2023
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
August 31, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch
August 17, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments
August 15, 2023
Via
Benzinga
Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher
August 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Design Therapeutics Are Plummeting on Tuesday
August 15, 2023
Via
The Motley Fool
Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 15, 2023
Via
Benzinga
Crude Oil Down 2%; Home Depot Posts Upbeat Earnings
August 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
Dow Falls Over 200 Points; US Retail Sales Top Expectations
August 15, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 15, 2023
Via
Benzinga
Why Is Design Therapeutics Stock Moving Lower Today?
August 15, 2023
Via
Benzinga
Why Delcath Systems Shares Are Trading Higher By Around 58%; Here Are 20 Stocks Moving Premarket
August 15, 2023
Via
Benzinga
Exposures
Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 15, 2023
Via
InvestorPlace
Design Therapeutics, Getty Images, Sea Limited And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
August 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 14, 2023
Via
Benzinga
Design Therapeutics Provides Pipeline Update and Reports Second Quarter 2023 Financial Results
August 14, 2023
From
Design Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.